LYONS GARY A
Reporting owner on Forms 3, 4 and 5, CIK 1123343.
LYONS GARY A reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCIK 914475 | director | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-17 | M exercised | +15,000 | $53.64 | 137,141 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-17 | S sold | -1,200 | $163.1106 | 135,941 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-17 | S sold | -4,011 | $163.938 | 131,930 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-17 | S sold | -5,689 | $165.1547 | 126,241 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-17 | S sold | -4,100 | $165.8968 | 122,141 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCNon-Qualified Stock Option, derivative | 2026-11-17 | M exercised | -15,000 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001123343-26-000013 | NEUROCRINE BIOSCIENCES INC | 2026-11-19 |